Dimensional Fund Advisors LP Acquires 107,461 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Dimensional Fund Advisors LP increased its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,244,938 shares of the company's stock after acquiring an additional 107,461 shares during the quarter. Dimensional Fund Advisors LP owned approximately 4.51% of ZimVie worth $17,367,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Barclays PLC increased its stake in shares of ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company's stock valued at $690,000 after purchasing an additional 33,529 shares during the period. JPMorgan Chase & Co. boosted its holdings in ZimVie by 66.7% during the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after buying an additional 73,395 shares in the last quarter. Monarch Capital Management Inc. lifted its position in shares of ZimVie by 6.2% in the 4th quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company's stock valued at $915,000 after acquiring an additional 3,847 shares in the last quarter. SG Americas Securities LLC boosted its stake in ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after purchasing an additional 1,508 shares during the period. Finally, EMC Capital Management boosted its stake in ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after purchasing an additional 4,414 shares during the period. Institutional investors and hedge funds own 95.63% of the company's stock.

ZimVie Stock Performance

Shares of ZIMV traded up $0.08 during trading hours on Tuesday, reaching $8.99. 60,858 shares of the company traded hands, compared to its average volume of 133,418. The stock has a market cap of $250.34 million, a P/E ratio of -0.69 and a beta of 2.16. The stock's fifty day moving average is $10.24 and its 200 day moving average is $12.60. ZimVie Inc. has a 1-year low of $8.56 and a 1-year high of $22.40. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.06. The business had revenue of $112.00 million for the quarter, compared to analysts' expectations of $113.10 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. Equities research analysts anticipate that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ZIMV shares. B. Riley initiated coverage on shares of ZimVie in a research note on Thursday, April 10th. They set a "buy" rating and a $16.00 target price for the company. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.